Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bethanechol chloride for prevention of bladder dysfunction after radical hysterectomy
ISRCTN92687416Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Bladder diseases comparing Bethanechol chloride with Placebo (2 arms). Primary endpoint: Incidence of urethral catheter removal at 1 week postoperatively. Started Aug 2007; status: completed.
02
Drugs
bethanechol
03
Conditions
Bladder diseases
Beyond the preview
Go deeper on ISRCTN92687416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN92687416.